Acute, symptomatic seizures or epilepsy may complicate the course of hepatic disease.
Choosing the most appropriate antiepileptic drug in this setting represents a difficult …

Introduction: Carbamazepine (CBZ) is used for the treatment of epilepsy and other
neurological and psychiatric disorders. The occurrence of adverse reactions (ADRs) to CBZ …

В руководстве представлены результаты 60-летней работы автора в области детской
и взрослой неврологии и эпилептологии. Впервые эпилептология представлена в …

Objective To evaluate factors predicting efficacy, retention, and tolerability of add‐on
brivaracetam (BRV) in clinical practice. Methods A multicenter, retrospective cohort study …

Inflammatory pain is the most common type of pain that is treated clinically. The use of
currently available treatments (classic analgesics-NSAIDs, paracetamol and opioids) is …

Background and Purpose Variants in SCN8A, the NaV1. 6 channel's coding gene, are
characterized by a variety of symptoms, including intractable epileptic seizures, psychomotor …

Purpose Pooled evaluation of the key efficacy and safety profile of eslicarbazepine acetate
(ESL) added‐on to stable antiepileptic therapy in adults with focal‐onset seizures. Methods …

Monotherapy remains the standard initial therapy of epilepsy, but when the first antiepileptic
drug (AED) fails, combination therapy may be considered. The choice of combination …

Introduction Eslicarbazepine acetate was first approved in the European Union in 2009 as
adjunctive therapy in adults with partial-onset seizures with or without secondary …

This article describes clinical antiepileptic drugs (AEDs) that are available for treatment of
epilepsy. Epilepsy is characterized by repeated occurrence of seizures. Epileptic seizures …